Cargando…

Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson’s and Alzheimer’s Diseases

The main risk of Alzheimer’s disease (AD) and Parkinson’s disease (PD), the two most common neurodegenerative pathologies, is aging. In contrast to sporadic cases, whose symptoms appear at >60 years of age, familial PD or familial AD affects younger individuals. Finding early biological markers o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco, Rafael, Navarro, Gemma, Martínez-Pinilla, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651599/ https://www.ncbi.nlm.nih.gov/pubmed/31277513 http://dx.doi.org/10.3390/ijms20133297

Ejemplares similares

Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System
por: Franco, Rafael, et al.
Publicado: (2019)

Hormetic and Mitochondria-Related Mechanisms of Antioxidant Action of Phytochemicals
por: Franco, Rafael, et al.
Publicado: (2019)

Antioxidants versus Food Antioxidant Additives and Food Preservatives
por: Franco, Rafael, et al.
Publicado: (2019)

The Epigenetic Cytocrin Pathway to the Nucleus. Epigenetic Factors, Epigenetic Mediators, and Epigenetic Traits. A Biochemist Perspective
por: Navarro, Gemma, et al.
Publicado: (2017)

Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease
por: Martínez-Pinilla, Eva, et al.
Publicado: (2016)

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization
por: Franco, Rafael, et al.
Publicado: (2016)

A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression
por: Navarro, Gemma, et al.
Publicado: (2017)

Antioxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents
por: Franco, Rafael, et al.
Publicado: (2021)

PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death
por: Gandhi, Sonia, et al.
Publicado: (2009)

Adenosine A(2A) and A(3) Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling
por: Lillo, Alejandro, et al.
Publicado: (2020)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Natural Compounds as Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors
por: Serrano-Marín, Joan, et al.
Publicado: (2020)

T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease
por: Tabata, Yoshikuni, et al.
Publicado: (2018)

Embryonic development of selectively vulnerable neurons in Parkinson’s disease
por: Oliveira, Miguel A. P., et al.
Publicado: (2017)

Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage
por: Franco, Rafael, et al.
Publicado: (2021)

Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease
por: Leng, Kun, et al.
Publicado: (2021)

On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
por: Giguère, Nicolas, et al.
Publicado: (2018)

Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
por: Brazdis, Razvan-Marius, et al.
Publicado: (2020)

Cuprizone-Induced Neurotoxicity in Human Neural Cell Lines Is Mediated by a Reversible Mitochondrial Dysfunction: Relevance for Demyelination Models
por: Martínez-Pinilla, Eva, et al.
Publicado: (2021)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
por: Cai, Huaibin, et al.
Publicado: (2014)

The olfactory Olfr-78/51E2 receptor interacts with the adenosine A(2A) receptor. Effect of menthol and 1,8-cineole on A(2A) receptor-mediated signaling
por: Lillo, Jaume, et al.
Publicado: (2023)

Differential vulnerability of the cerebellum in healthy ageing and Alzheimer’s disease
por: Gellersen, Helena M., et al.
Publicado: (2021)

One-way or two-way sweet link between theobromine and depression?
por: Franco, Rafael, et al.
Publicado: (2023)

Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
por: Sierra, Salvador, et al.
Publicado: (2014)

Maternal imprinting on cognition markers of wild type and transgenic Alzheimer’s disease model mice
por: Zamarbide, Marta, et al.
Publicado: (2018)

Neuronal death in Alzheimer’s disease and therapeutic opportunities
por: Donev, Rossen, et al.
Publicado: (2009)

Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS
por: Allodi, Ilary, et al.
Publicado: (2016)

Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APP(swe) Alzheimer’s Disease Mouse Model
por: Zamarbide, Marta, et al.
Publicado: (2022)

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
por: Greenough, Mark A., et al.
Publicado: (2022)

Functional Genomics of Brain Aging and Alzheimer’s Disease: Focus on Selective Neuronal Vulnerability
por: Wang, Xinkun, et al.
Publicado: (2010)

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons
por: Franco, Rafael, et al.
Publicado: (2023)

Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection
por: Nury, Thomas, et al.
Publicado: (2020)

A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson’s disease
por: Tang, Lei, et al.
Publicado: (2023)

Isoflurane Increases Neuronal Cell Death Vulnerability by Downregulating miR-214
por: Yan, Hailiang, et al.
Publicado: (2013)

Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease
por: Aguila, Julio, et al.
Publicado: (2021)

Neuronal cell death mechanisms in Alzheimer’s disease: An insight
por: Goel, Parul, et al.
Publicado: (2022)

Selective Vulnerability of Neurons in Layer II of the Entorhinal Cortex during Aging and Alzheimer's Disease
por: Stranahan, Alexis M., et al.
Publicado: (2010)

Neurons in Vulnerable Regions of the Alzheimer’s Disease Brain Display Reduced ATM Signaling123
por: Shen, Xuting, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5i9s26o8vbdls76k2nl0jajqcm